Linkedin

Category: Blogs

2nd Immuno-Oncology Conference 2026: Explore the Agenda, Meet Global Speakers, and Discover the Future of Cancer Immunotherapy

Posted on by veridonglobal.dev@gmail.com

The landscape of cancer treatment is rapidly transforming through advances in immunotherapy, biomarker discovery, precision medicine, and personalized oncology approaches. The 2nd Immuno-Oncology & Biomarker Summit 2026 will take place on 19–20 October 2026 in Philadelphia, USA brings together leading scientists, clinicians, pharmaceutical executives, biotechnology innovators, diagnostics experts, and research organizations to explore the breakthroughs shaping the future of cancer care.

This premier conference provides a collaborative environment where industry leaders can exchange knowledge, present groundbreaking research, build partnerships, and discover opportunities that accelerate the development of next-generation immuno-oncology solutions.

Explore the Latest Advances Through a Cutting-Edge Conference Agenda

The summit agenda is designed to address the most important challenges and innovations in immuno-oncology and biomarker-driven cancer treatment.

Key discussion areas include:

  • Next-generation immunotherapies and immune checkpoint strategies
  • CAR-T, TCR, and engineered cell therapies for solid tumors
  • Bispecific antibodies and immune engager platforms
  • Cancer vaccines and personalized immunotherapy approaches
  • Tumor microenvironment and immune resistance mechanisms
  • Biomarker discovery and validation strategies
  • Companion diagnostics (CDx) development
  • AI, machine learning, and multi-omics in oncology research
  • Spatial biology and single-cell technologies
  • Liquid biopsy and precision oncology applications
  • Clinical trial advancements and translational research

Through keynote presentations, expert-led panels, scientific presentations, and networking sessions, attendees will gain valuable insights into emerging technologies and strategies transforming the immuno-oncology ecosystem.

Connect with World-Class Experts and Industry Thought Leaders

The summit will feature an influential speaker faculty consisting of leading researchers, executives, and innovators from pharmaceutical companies, biotechnology organizations, academic institutions, and healthcare technology companies.

The speaker lineup includes experts such as:

  • Rakesh Dixit – Co-Founder, President, CSO, Regio Biosciences
  • Jun Ren – Senior Scientist, AstraZeneca
  • Syed Kazmi – CEO, Magnacor Therapeutics
  • Douglas Palmer – Executive Director Head IO Translational Medicine, AstraZeneca
  • Kevin Horgan – Head. R&D, Melius MicroBiomics
  • Pratik Rane  – Director, CORE Oncology, Merck
  • George Pell – Principal, Chief Strategy Officer, Seven
  • Robert Kemp – President, MG Lifesciences
  • Stefan Glueck – Chief Medical Officer, Konsuld
  • Lokesh Agrawal – Chief (Acting) Biorepositories & Biospecimen Research Branch, National Cancer Institute, NIH
  • Dr. Jennifer Onwumeh-Okwundu – Director, Clinical Science, Pfizer
  • Sarbajit Mukherjee – Chief, GI Medical Oncology, Baptist Health South Florida
  • Raluca Budiu-Predoiu – Director, Precision Medicine IO, CDx Strategy Lead, AbbVie
  • Gary Steven Friedman – Chair, Biomarker Data Repository Oversight Committee, Critical Path Institute (C-Path)
  • Usha Singh – Global Precision Medicine Dx Team Lead, Johnson & Johnson
  • Dr. Ashok Srivastava – CEO, rTR Technovation Corporation

The conference will continue to bring together experts who are advancing novel therapies, biomarker strategies, clinical applications, and commercial opportunities in oncology.

Become a Speaker: Share Your Expertise with the Global Immuno-Oncology Community

Are you leading innovative research, developing breakthrough technologies, or advancing clinical solutions in immuno-oncology?

The summit provides an exclusive opportunity for researchers, clinicians, industry experts, and technology leaders to become part of the speaker community and share their expertise with a highly focused audience.

Speaking at the conference allows you to:

  • Present your latest research findings and scientific discoveries
  • Highlight your organization’s innovations and pipeline developments
  • Engage with global experts and decision-makers
  • Increase visibility among pharma, biotech, and healthcare leaders
  • Contribute to discussions shaping the future of cancer immunotherapy

Experts working in immunotherapy, biomarkers, companion diagnostics, precision medicine, cell therapy, and translational oncology are invited to explore speaking opportunities and become a voice in the next generation of cancer innovation.

Become a Sponsor: Position Your Brand at the Forefront of Oncology Innovation

The 2nd Immuno-Oncology & Biomarker Summit 2026 offers strategic sponsorship opportunities for organizations looking to strengthen their presence within the global oncology community.

By becoming a sponsor, your organization can:

  • Showcase your latest technologies, platforms, products, and services
  • Connect with senior leaders from pharmaceutical and biotechnology companies
  • Build valuable partnerships with researchers and healthcare innovators
  • Generate new business opportunities through targeted networking
  • Enhance brand visibility among a specialized scientific audience
  • Demonstrate leadership in advancing cancer research and treatment solutions

Sponsorship opportunities are designed for companies working across:

  • Immunotherapy development
  • Biotechnology and pharmaceutical research
  • Biomarker discovery platforms
  • Companion diagnostics
  • Clinical research solutions
  • AI and healthcare technologies
  • Laboratory and life science solutions

Whether you are launching a new technology, expanding your industry network, or seeking strategic collaborations, sponsoring the summit provides a powerful platform to connect with the right audience and create meaningful business impact.

Exhibit and Partner with Global Oncology Leaders

Organizations can also participate as exhibitors and strategic partners to showcase their solutions directly to researchers, decision-makers, and potential collaborators.

Exhibiting provides opportunities to:

  • Demonstrate innovative products and technologies
  • Meet potential partners and customers
  • Build relationships with scientific and business leaders
  • Increase awareness within the immuno-oncology marketplace

Be Part of the Future of Cancer Treatment

The 2nd Immuno-Oncology & Biomarker Summit 2026 is more than a conference—it is a meeting point for innovation, collaboration, and scientific progress.

Join the global community of researchers, clinicians, pharmaceutical leaders, biotech pioneers, and technology innovators working together to transform cancer treatment.

Become a Speaker. Become a Sponsor. Become a Partner. Be part of the future of immuno-oncology.

Why Attend an Immuno-Oncology Conference in the USA in 2026?

Posted on by veridonglobal.dev@gmail.com

The field of immuno-oncology is transforming cancer care at an unprecedented pace. From next-generation cell therapies and antibody-drug conjugates (ADCs) to biomarker-driven precision medicine and AI-powered diagnostics, groundbreaking discoveries are reshaping how cancer is diagnosed, treated, and monitored.

For researchers, clinicians, pharmaceutical professionals, biotech innovators, and healthcare executives, attending an immuno-oncology conference is one of the most effective ways to stay ahead of these advancements. If you’re planning your professional development in 2026, the United States offers one of the world’s most dynamic environments for cancer research, clinical innovation, and industry collaboration.

Why Attend the 2nd Immuno-Oncology & Biomarker Summit 2026?

Scheduled for 19–20 October 2026 in Philadelphia, USA, the 2nd Immuno-Oncology & Biomarker Summit 2026 will bring together senior decision-makers from pharmaceutical companies, biotechnology firms, academia, diagnostics, and clinical research organizations. The summit focuses on practical, real-world applications of immuno-oncology and biomarker science through keynote presentations, panel discussions, technical sessions, and dedicated networking opportunities. Topics include advanced immunotherapies, precision oncology, translational research, companion diagnostics, clinical trials, and AI-enabled biomarker strategies.

Register Early and Plan Your Travel

International delegates are encouraged to register early to secure their place and take advantage of available travel and accommodation options.

Planning ahead allows attendees to:

  • Secure early registration
  • Book convenient hotel accommodations
  • Arrange international travel
  • Schedule networking meetings in advance
  • Maximize participation in scientific and business sessions

Whether you’re a researcher, clinician, biotech innovator, pharmaceutical executive, or healthcare professional, attending an immuno-oncology conference in the USA provides an unparalleled opportunity to learn from global experts, discover breakthrough research, and build partnerships that accelerate the future of cancer treatment.

Whether you’re attending to learn, network, or showcase your solutions, now is the perfect time to secure your participation. Register as a delegate or become a sponsor to engage with the global immuno-oncology community.

Experience the USA’s Leadership in Biotech and Immuno-Oncology

The United States continues to lead the global biotechnology and life sciences industry, making it the ideal destination for immuno-oncology conferences. Renowned innovation hubs such as Boston, Philadelphia, San Diego, and the San Francisco Bay Area are home to leading pharmaceutical companies, biotechnology startups, academic medical centers, and world-class cancer research institutions.

These ecosystems drive innovation in:

  • Cancer immunotherapy
  • Precision oncology
  • Biomarker discovery
  • Companion diagnostics
  • Cell and gene therapies
  • Artificial intelligence in oncology

Philadelphia, the host city for the 2nd Immuno-Oncology & Biomarker Summit 2026, has emerged as one of the fastest-growing life sciences hubs in the United States. The city offers access to cutting-edge research institutions, biotechnology companies, healthcare systems, and a thriving innovation ecosystem that fosters scientific collaboration and translational research.

Gain Insights into the Latest Clinical Trials and Research

One of the greatest advantages of attending an immuno-oncology conference in the USA is direct access to the latest clinical research and emerging therapeutic strategies.

Leading scientists and industry experts present new findings from ongoing and completed clinical trials, providing attendees with valuable insights into:

  • Next-generation checkpoint inhibitors
  • CAR-T and TCR cell therapies
  • Bispecific antibodies
  • Antibody-drug conjugates (ADCs)
  • mRNA cancer vaccines
  • Tumor microenvironment research
  • Novel immune targets
  • Combination immunotherapy strategies

The 2nd Immuno-Oncology & Biomarker Summit 2026 also highlights advances in biomarker-driven precision medicine, including liquid biopsy, measurable residual disease (MRD), spatial biology, AI-driven imaging biomarkers, and multi-omics integration. These innovations are helping clinicians improve patient selection, optimize treatment decisions, and accelerate personalized cancer care.

Learn How Biomarkers Are Shaping Precision Oncology

Modern immuno-oncology increasingly depends on biomarkers to identify the right treatment for the right patient.

Conference sessions dedicated to biomarker science allow attendees to explore:

  • Companion diagnostics (CDx)
  • Predictive and prognostic biomarkers
  • Clinical trial optimization
  • Biomarker validation
  • Regulatory considerations
  • Real-world evidence
  • AI-enabled biomarker discovery

Understanding how biomarkers influence immunotherapy development can help researchers and pharmaceutical companies improve clinical outcomes while reducing development timelines.

Build Valuable Connections Across Pharma and Biotech

Scientific knowledge is only one part of the conference experience. Equally important are the networking opportunities available throughout the event.

An immuno-oncology conference in the USA brings together professionals from across the healthcare ecosystem, including:

  • Global pharmaceutical companies
  • Biotechnology organizations
  • Clinical research organizations (CROs)
  • Academic institutions
  • Diagnostic developers
  • Regulatory experts
  • Investors and venture capital firms
  • Healthcare providers

These interactions often lead to research collaborations, licensing opportunities, strategic partnerships, recruitment, and future clinical trial initiatives.

Whether you’re seeking collaborators for translational research or exploring commercial partnerships, face-to-face networking remains one of the most valuable aspects of attending industry conferences.

Join the 2nd Immuno-Oncology & Biomarker Summit 2026 in Philadelphia and become part of the conversations driving the next generation of precision oncology and cancer immunotherapy.

Immuno-Oncology Conferences 2026: Top Global Events You Should Attend

Posted on by veridonglobal.dev@gmail.com

Immuno-oncology (IO) continues to redefine the future of cancer treatment in 2026, driving breakthroughs in checkpoint inhibitors, CAR-T therapies, bispecific antibodies, tumor microenvironment research, and biomarker-driven precision medicine. As the field rapidly evolves, global conferences have become essential platforms for collaboration between biotech leaders, pharma companies, clinicians, and researchers.

From academic-heavy meetings to industry-focused summits, 2026 offers a powerful lineup of immuno-oncology events across the USA, Europe, and global biotech hubs.

Below is a curated guide to the top immuno-oncology conferences in 2026—including key global meetings and why the Philadelphia-based Veridon Global Immuno-Oncology & Biomarker Summit 2026 stands out as a must-attend event.

Top Immuno-Oncology Conferences 2026 (Global Overview)

1. Veridon Global Immuno-Oncology & Biomarker Summit 2026 (Philadelphia, USA)

Location: Philadelphia, USA
Date: October 19–20, 2026
Organized by Veridon Global

The 2nd Immuno-Oncology and Biomarker Summit 2026 in Philadelphia is emerging as one of the most strategically positioned IO meetings in the USA, uniquely combining immuno-oncology innovation with biomarker-driven precision medicine. Unlike broader global conferences, this summit is highly focused on translational execution, bridging the gap between discovery science and real-world clinical implementation.

Why Philadelphia is Becoming a Key IO Hub

Philadelphia is home to leading academic hospitals, oncology research centers, and biotech ecosystems. This makes the city a natural convergence point for:

  • Clinical oncology innovation
  • Biomarker validation studies
  • Early-phase drug development
  • Industry–academic partnerships

Register now for the Immuno-Oncology & Biomarker Conference 2026 in Philadelphia
Secure early bird pricing and guaranteed access to high-impact sessions.

Sponsorship Opportunities Available
Position your brand at the forefront of immuno-oncology innovation and precision medicine.

2. AACR Immuno-Oncology Conference 2026 – USA

Location: Los Angeles, USA
Date February 18–21, 2026
Organized by the American Association for Cancer Research (AACR), this flagship event brings together leading scientists and clinicians to present cutting-edge research in immunotherapy, cancer vaccines, and translational oncology.

Key Focus:

  • Immune checkpoint therapy
  • Tumor immunology mechanisms
  • Early clinical trials
  • Cancer vaccines and cellular therapies

3. Immuno-Oncology 360° Summit 2026 – USA

Location: Boston, USA
Date: February 10–12, 2026

A major industry-driven conference connecting science, business, and investment communities in immuno-oncology.

Key Focus:

  • IO drug development pipeline
  • Biomarkers and diagnostics
  • Cell therapy innovation
  • Clinical development strategies

4. SITC Immuno-Oncology Drug Development Summit 2026 – Switzerland

Location: Lausanne, Switzerland
Date: September 3–4, 2026

A focused meeting led by the Society for Immunotherapy of Cancer (SITC), emphasizing translational research and clinical development.

Key Focus:

  • CAR-T and T-cell therapies
  • Bispecific antibodies
  • IO combination strategies
  • Regulatory and clinical trial design

5. ESMO Immuno-Oncology Congress 2026 – UK

Location: London, UK
Date: December 14–16, 2026

A globally recognized oncology congress focusing on clinical application of immunotherapies.

Key Focus:

  • Real-world IO treatment outcomes
  • Combination therapies
  • Biomarkers in clinical practice
  • Patient-centric oncology care

6. BIO International Convention 2026 – USA

Location: San Diego, USA
Date: June 22–25, 2026

While not IO-exclusive, BIO 2026 is the largest biotech partnering event globally, making it highly relevant for immuno-oncology companies.

Key Focus:

  • Biotech partnerships
  • Oncology drug pipelines
  • AI and precision medicine
  • Investment and licensing deals

What Makes the Veridon Global Summit Stand Out

Focused Dual-Track Structure

  • Immuno-Oncology Innovation Track
  • Biomarkers & Companion Diagnostics Track

Core Topics Include

  • Next-generation immunotherapies (CAR-T, bispecific, ADCs)
  • Tumor microenvironment & resistance mechanisms
  • Liquid biopsy & minimal residual disease (MRD)
  • AI-driven oncology and multi-omics integration
  • Clinical translation of biomarkers into practice

Why It Matters

While larger conferences provide scale, the Philadelphia summit delivers depth, specificity, and actionable insights, making it ideal for:

  • Pharma R&D leaders
  • Biomarker scientists
  • Clinical trial designers
  • Diagnostic developers
  • Precision oncology innovators

Global IO Conference Comparison (2026)

ConferenceLocationStrengthBest For
AACR IO 2026USA (Los Angeles)Academic research depthScientists & translational researchers
IO360° 2026USA (Boston)Industry + investmentBiotech & pharma executives
SITC SummitSwitzerlandDrug development focusClinical & regulatory teams
ESMO IO CongressUKClinical applicationOncologists & healthcare systems
BIO 2026USA (San Diego)Networking & partnershipsInvestors & biotech leaders
Veridon Global IO SummitUSA (Philadelphia)Biomarker + IO integrationPrecision oncology & translational science

Why You Should Attend the Philadelphia IO Summit 2026

The Veridon Global Immuno-Oncology & Biomarker Summit 2026 stands out because it addresses a critical gap in the IO ecosystem:
– turning biomarker science into real clinical decision-making.

With focused discussions on:

  • AI in oncology
  • Liquid biopsy applications
  • Biomarker-driven therapy selection
  • Next-generation IO combinations

It provides a high-impact environment for professionals who want practical, translational outcomes—not just theory.

Final Takeaway

Immuno-oncology in 2026 is no longer just about discovery, it is about translation, precision, and real-world implementation. While global conferences like AACR, ESMO, and BIO continue to dominate scale and visibility, specialized meetings like the Veridon Global Philadelphia Summit are becoming increasingly important for deep scientific progress.

If your goal is to stay ahead in immunotherapy innovation, biomarker development, and clinical translation, attending the right Immuno-oncology conference can define your year.

2nd Immuno-Oncology and Biomarker Conference 2026: Shaping the Future of Cancer Immunotherapy

Posted on by veridonglobal.dev@gmail.com

The field of cancer treatment is evolving rapidly, driven by breakthroughs in immunotherapy, biomarker research, and precision medicine. As researchers and industry leaders seek innovative approaches to improve patient outcomes, the demand for specialized scientific gatherings continues to grow. The 2nd Immuno-Oncology and Biomarker Summit 2026 is set to be one of the most anticipated Immuno-Oncology Conferences of the year, bringing together experts from across the oncology ecosystem.

Scheduled for 19–20 October 2026 in Philadelphia, USA, this premier conference will serve as a platform for knowledge exchange, scientific collaboration, and discussions on the latest developments in immuno-oncology and biomarker-driven therapies.

Why Immuno-Oncology Conferences Matter in 2026

Cancer immunotherapy has transformed the treatment landscape by enabling the immune system to recognize and attack cancer cells more effectively. However, despite significant progress, challenges such as treatment resistance, patient selection, and biomarker validation remain key areas of research.

An Immuno-Oncology Conference provides a dedicated environment where scientists, clinicians, pharmaceutical companies, biotechnology innovators, and academic researchers can explore solutions to these challenges. Such events play a critical role in accelerating research and fostering collaborations that drive the next generation of cancer treatments.

Register at https://immunooncologyconference.com/upcoming-conferences/uk-edition/immuno-oncology-biomarker-summit-2026-registration-2/

Networking and Collaboration Opportunities

One of the greatest benefits of attending an Immuno-Oncology Conference is the opportunity to connect with industry leaders and decision-makers.

The summit will facilitate discussions among:

  • Pharmaceutical companies
  • Biotechnology firms
  • Academic institutions
  • Clinical research organizations
  • Healthcare providers
  • Diagnostic technology companies

These interactions can lead to strategic partnerships, collaborative research initiatives, and new business opportunities that advance innovation in cancer care.

Become a Sponsor at https://immunooncologyconference.com/upcoming-conferences/uk-edition/become-a-sponsor-2/

What to Expect at the 2nd Immuno-Oncology and Biomarker Summit 2026

The summit is designed to address the most pressing topics in oncology research and drug development. Attendees can expect expert-led presentations, panel discussions, case studies, and networking opportunities focused on advancing precision medicine.

Key discussion areas include:

  • Biomarker discovery and validation
  • Precision oncology strategies
  • Advances in cancer immunotherapy
  • Companion diagnostics development
  • Clinical trial innovation
  • Translational oncology research
  • AI-driven biomarker analysis
  • Emerging immunotherapy combinations
  • Liquid biopsy technologies
  • Personalized cancer treatment approaches

As a specialized Immuno-Oncology Conference, the event aims to bridge the gap between scientific discovery and clinical application.

The Growing Importance of Biomarkers in Immuno-Oncology

Biomarkers have become essential tools in modern cancer care. They help identify patients who are most likely to respond to specific therapies, improving treatment outcomes while reducing unnecessary interventions.

During the conference, leading experts will discuss how biomarker technologies are transforming oncology research through:

Predictive Biomarkers

Predictive biomarkers enable clinicians to determine which patients may benefit from a particular immunotherapy treatment.

Prognostic Biomarkers

These biomarkers provide insights into disease progression and patient outcomes.

Companion Diagnostics

Companion diagnostics are increasingly important for matching therapies with the right patient populations and supporting regulatory approvals.

Multi-Omics Approaches

Researchers are leveraging genomics, proteomics, transcriptomics, and metabolomics to uncover novel biomarkers and therapeutic targets.

Emerging Trends to Be Highlighted at This Immuno-Oncology Conference

Artificial Intelligence in Biomarker Research

AI and machine learning are helping researchers analyze complex biological datasets more efficiently than ever before. These technologies are accelerating biomarker identification and improving treatment predictions.

Liquid Biopsy Innovation

Liquid biopsy continues to gain attention as a minimally invasive method for cancer detection, monitoring, and treatment selection. Advances in this area are expected to be a major topic of discussion.

Combination Immunotherapies

Researchers are increasingly exploring combination approaches that integrate checkpoint inhibitors, targeted therapies, and novel immunotherapeutic strategies to improve patient outcomes.

Precision Medicine Integration

Precision medicine remains at the forefront of oncology innovation, with biomarker-guided treatment decisions becoming a standard component of modern cancer care.

Why Philadelphia Is an Ideal Destination for an Immuno-Oncology Conference

Philadelphia has emerged as a major center for life sciences, biotechnology, and pharmaceutical innovation. The region is home to renowned research institutions, leading healthcare organizations, and a thriving biotech ecosystem.

Hosting the 2nd Immuno-Oncology and Biomarker Summit in Philadelphia provides attendees with access to one of the most dynamic oncology research communities in the United States.

Who Should Attend the 2nd Immuno-Oncology and Biomarker Summit 2026?

This Immuno-Oncology Conference is designed for professionals involved in oncology research, drug development, and precision medicine, including:

  • Oncology researchers
  • Immunology scientists
  • Biomarker specialists
  • Clinical development professionals
  • Pharmaceutical executives
  • Biotechnology innovators
  • Translational medicine experts
  • Clinical trial managers
  • Regulatory affairs professionals
  • Academic researchers

Whether participants are developing next-generation therapies or seeking new collaboration opportunities, the summit offers valuable insights and networking opportunities.

The Future of Immuno-Oncology and Biomarker Research

As the oncology landscape continues to evolve, biomarker-driven approaches and personalized immunotherapies will play an increasingly important role in improving patient outcomes.

The 2nd Immuno-Oncology and Biomarker Summit 2026 aims to provide attendees with actionable insights into emerging technologies, scientific breakthroughs, and industry trends shaping the future of cancer treatment.

For researchers, clinicians, and industry professionals seeking to stay ahead of developments in precision oncology, this Immuno-Oncology Conference offers a unique opportunity to gain knowledge, build partnerships, and contribute to the next wave of innovation in cancer research.

Conclusion

The 2nd Immuno-Oncology and Biomarker Summit 2026 stands out as a premier Immuno-Oncology Conference dedicated to advancing cancer immunotherapy and biomarker science. By bringing together global experts, innovative companies, and leading researchers, the event will help drive meaningful progress in precision medicine and oncology drug development.

As the demand for personalized cancer therapies continues to grow, conferences focused on immuno-oncology and biomarkers will remain essential platforms for collaboration, discovery, and scientific advancement.

Real World Evidence Conference Sponsorship: Packages, Benefits & Opportunities

Posted on by veridonglobal.dev@gmail.com

The Real World Evidence Conference Sponsorship at Hilton Garden Inn Camden Waterfront Philadelphia, USA scheduled for 08–09 June 2026, is one of the most influential gatherings for healthcare, pharmaceutical, and life sciences professionals. This premier event brings together global industry leaders, payers, researchers, and solution providers to explore the evolving role of real-world evidence in shaping market access and healthcare decision-making. For organizations aiming to increase brand visibility, engage with senior decision-makers, and establish thought leadership, Real World Evidence Conference sponsorship offers unmatched opportunities to make a lasting impact. Whether you are a global pharmaceutical company, a biotech innovator, or a healthcare solutions provider, sponsoring a Real World Evidence Conference allows you to connect with key industry stakeholders and maximize your impact.

Explore all sponsorship opportunities and secure your spot here: Become a Sponsor

Real World Evidence Conference Sponsorship Packages

Choosing the right sponsorship package ensures your organization achieves maximum ROI and visibility. Here are the available packages:

  • Platinum Sponsor – Premium branding, top-tier visibility, and priority access to networking events.
  • Gold Sponsor – Exclusive exposure and opportunities to engage with senior decision-makers.
  • Silver Sponsor – Targeted branding in breakout sessions and conference materials.
  • Bronze Sponsor – Budget-friendly branding opportunities for strategic impact.
  • Conference Exhibitor – Showcase your products and services at dedicated exhibition spaces.
  • Conference Speaking (15 to 30 Minutes) – Demonstrate thought leadership with expert presentations.
  • Networking Partner – Facilitate meaningful connections during curated networking sessions.
  • Lanyard Sponsor – Achieve everyday visibility as attendees wear branded lanyards.
  • Associate Sponsor – Gain recognition as a supporting partner while strengthening your presence.

Benefits of Sponsoring a Real World Evidence Conference

Investing in Real World Evidence Conference sponsorship goes beyond brand exposure. Here’s why leading organizations participate:

  1. Unparalleled Brand Visibility with Tailormade Marketing Plans
    Reach your target audience with customized marketing campaigns across digital, onsite, and post-event channels.
  2. Engage with Senior Decision-Makers
    Connect directly with executives, payers, and industry leaders who drive critical business decisions.
  3. Flexible, Tailored Packages
    Select a package that aligns perfectly with your objectives, budget, and brand strategy.
  4. Lead Generation & ROI-Driven Outcomes
    Generate qualified leads, track engagement, and achieve measurable business results.
  5. Thought Leadership Opportunities
    Position your brand as an authority through speaking slots, panel discussions, and interactive sessions.

Why Real World Evidence Conference Sponsorship Matters

Sponsoring a Real World Evidence Conference is a strategic investment that ensures your organization:

  • Gains credibility and recognition in healthcare and life sciences.
  • Engages with the right audience efficiently.
  • Drives qualified leads and measurable ROI.
  • Strengthens thought leadership in RWE and market access.

With sponsorship packages ranging from Platinum to Associate, there’s a solution for every organization seeking maximum impact.

Don’t miss this opportunity to elevate your brand and connect with decision-makers: Become a Sponsor Today.

 

FPS Pharma Leads the Future of High-Containment Manufacturing at EuroPotent 360 Summit

Posted on by Federica Fazio

As the pharmaceutical industry evolves toward targeted therapies and increasingly potent and complex APIs, process control, precision and proper containment are more critical than ever.

This is why we’re excited to share that FPS Pharma is the Gold Sponsor at the upcoming Veridon Global event 2nd Annual EuroPotent 360 Summit a premier forum where industry leaders, innovators, and change-makers converge to shape the future of healthcare and pharmaceutical technology.

FPS Pharma mission is to ensure the utmost efficiency, safety and compliance in critical pharmaceutical manufacturing processes, especially in handling high-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs). With advanced containment isolators, innovative control systems, and next-level engineering solutions, FPS Pharma is empowering manufacturers to operate at new levels of excellence.

Why FPS Pharma stands out in containment and isolation technology

Pharmaceutical manufacturing increasingly depends on highly controlled systems for handling potent and sterile compounds.

What sets FPS Pharma high-containment isolators apart is not only their performance, but their design philosophy. These systems are engineered with the understanding that containment is not a constraint, but a catalyst. By enabling the safe handling of ultra-potent APIs, they unlock new possibilities in drug development, allowing manufacturers to explore new types of chemistry and to scale up with confidence. These custom isolators incorporate features such as closed transfer systems (RTPs, SBVs and others), automated cleaning (CIP/WIP), sterilization-in-place (SIP), real-time monitoring, and also advanced features such as robotic and voice-controlled systems. Every element is engineered to minimize contamination risks, maximize precision, optimize operational efficacy, and ensure compliance with the most stringent global standards.

For toxic applications, FPS Pharma develops negative-pressure custom isolators with turbulent airflow, designed to achieve containment levels from 10 µg/m3 to single-digit nanogram levels and below (from OEB 4 up to OEB 7).

Supporting next-generation HPAPI and ADC manufacturing

ADCs are continuously evolving and increasing their payload (cytotoxic drug) potency to increase their therapeutic efficacy. This leads to their success and to its rapid growth and to an increase in containment complexity. To meet this challenge, FPS Pharma has pioneered containment systems like OEB 7 isolators, representing the new frontier in ultra-potent API containment, which guarantee single-digit nanogram containment down to 1 ng/m3. Isolators).

FPS Pharma’s custom containment solutions can seamlessly integrate all the process phases and technologies, such as sampling and dispensing, reactor charging, filtration and drying, ANFD discharge, milling, micronization, filling, packaging and quality control, and customer’s equipment. This application-driven approach helps customers simplify process steps, minimize operator exposure risks, optimize workflow and ensure utmost product quality.

Innovation that improves both compliance and operational efficiency

In addition to FPS Pharma isolator technologies and micronization systems, FPS Pharma offers advanced glove leak testing devices such as GloveXpert, its patented wireless glove leak tester for isolators and RABS. It performs reliable and repeatable integrity testing on both gloves and glove ports using the positive pressure decay method, in full compliance with UNI EN ISO 14644-7.

Designed for speed, safety and ease of use, GloveXpert can complete a test in 4 to 9 minutes, perform up to 120 test cycles on a single charge, detect holes as small as 100 microns, and supports features such as RFID, Wi-Fi connectivity, and many other features which make glove testing easy, ultra-accurate and fast. It reflects FPS Pharma’s broader commitment to combining smart engineering with practical, inspection-ready solutions for pharmaceutical operations.

Looking Ahead: FPS Pharma at Veridon Global

As Veridon Global brings together leaders from across healthcare, life sciences, and technology, FPS Pharma’s role as Gold Sponsor underscores its strategic vision: to help the industry innovate boldly while operating within the highest standards of safety and compliance. From high-containment isolators to next-generation API manufacturing solutions, FPS Pharma continues to push boundaries and redefine what’s possible in pharmaceutical production.

We look forward to meaningful conversations at 2nd Annual EuroPotent 360 Summit — connecting, learning, and co-creating safer, smarter pharmaceutical futures. Stay tuned for more insights and highlights from the event!

Become a Sponsor at the Real World Evidence and Market Access Conference USA 2026

Posted on by veridonglobal.dev@gmail.com

In a healthcare landscape driven by real-world evidence (RWE), pricing innovation, and faster patient access, the ability to connect with the right stakeholders is more valuable than ever. The Real World Evidence and Market Access Conference USA Edition 2026, also known as the Evidence 360 Summit USA, is designed to bring together the very people shaping these decisions.

If your organization is looking to increase visibility, build credibility, and generate high-value partnerships, becoming a sponsor is not just an option—it’s a strategic move.

Secure your Sponsorship today at: https://veridonglobal.com/upcoming-conferences/2nd-annual-evidence-360-summit-usa-edition/become-a-sponsor-2nd-annual-evidence-360-summit-usa-edition/

Why the Evidence 360 Summit USA 2026 Matters

Scheduled for June 8–9, 2026, in Philadelphia, this summit is a premier platform focused on how RWE is transforming market access, pricing, and reimbursement strategies in the U.S. healthcare system.

It brings together:

  • Pharmaceutical and biotech leaders
  • Payers and policy makers
  • HEOR and RWE experts
  • Digital health and data innovators

As the U.S. market evolves with value-based care models, AI-driven evidence generation, and stricter pricing regulations, events like this become critical spaces for collaboration and decision-making.

Why Become a Sponsor?

Sponsoring the Evidence 360 Summit USA 2026 goes far beyond brand exposure—it places your organization at the center of industry conversations and business opportunities.

1. Position Your Brand as an Industry Leader

Sponsors gain opportunities to:

  • Deliver keynote or featured presentations
  • Join expert panel discussions
  • Showcase real-world case studies

This allows your organization to demonstrate expertise and influence how the industry evolves.

2. Direct Access to Decision-Makers

The summit attracts senior-level professionals and final decision-makers, making every interaction valuable.

With sponsorship, you can:

  • Participate in curated one-to-one meetings
  • Build relationships with key stakeholders
  • Engage in high-level networking sessions

These are not just conversations—they are opportunities for real business growth.

3. Generate High-Quality, Pre-Qualified Leads

Unlike traditional marketing channels, this event delivers:

  • A highly targeted audience
  • Professionals actively seeking solutions
  • Face-to-face engagement opportunities

This results in better lead quality and higher conversion potential.

4. Showcase Your Solutions in Action

Sponsors typically receive exhibition opportunities to:

  • Demonstrate products and services
  • Conduct live demos
  • Interact directly with potential clients

This hands-on approach builds trust, credibility, and faster decision-making.

5. Maximize Brand Visibility Before, During, and After the Event

Your brand is featured across:

  • Event marketing campaigns and email promotions
  • Social media and digital channels
  • On-site branding and conference materials

This ensures continuous exposure to a highly relevant audience.

Sponsorship Opportunities and Packages

While specific packages for the 2026 USA edition follow a tailored structure, typical sponsorship tiers include:

Platinum Sponsor

  • Premium branding across all channels
  • Prime speaking slot in the main agenda
  • Maximum networking and meeting opportunities
  • Exhibition booth and delegate passes

Gold Sponsor

  • Strong visibility and presentation opportunities
  • Dedicated one-to-one meetings
  • Exhibition space and marketing exposure

Silver Sponsor

  • Cost-effective entry with branding and networking access
  • Exhibition opportunities
  • Participation in key sessions

Across Veridon Global events, sponsorship packages often include speaking slots, exhibition booths, one-to-one meetings, social media promotion, and post-event attendee access, ensuring measurable ROI.

Who Should Sponsor This Conference?

This opportunity is ideal for organizations involved in:

  • Pharmaceuticals and biotechnology
  • Real-world data and analytics
  • Market access and pricing strategy
  • HEOR and value-based healthcare
  • Digital health and AI-driven solutions

If your goal is to influence healthcare decision-making and expand your presence in the U.S. market, this is the right platform.

What Makes This Event Stand Out?

The Evidence 360 Summit USA is not just another healthcare conference. It is a focused, high-impact event that emphasizes:

  • Real-world applications of RWE
  • Practical solutions to market access challenges
  • Collaboration between industry, payers, and regulators

It is designed to turn insights into action, making it highly valuable for sponsors seeking real outcomes.

Long-Term Value of Sponsorship

Beyond immediate visibility, sponsoring this event helps you:

  • Build long-term industry relationships
  • Strengthen brand authority
  • Stay aligned with emerging trends and regulations

In a competitive and rapidly evolving healthcare environment, these advantages contribute to sustained growth and market leadership.

Final Thoughts

The Real World Evidence and Market Access Conference USA Edition 2026 is where data meets decision-making and innovation meets access.

Becoming a sponsor allows you to:

  • Lead industry conversations
  • Connect with key stakeholders
  • Showcase your expertise
  • Drive real business results

If your organization is serious about making an impact in RWE, pricing, and market access, this is where you need to be.

 

How to Register for Real World Evidence and Market Access Conference 2026 in USA?

Posted on by veridonglobal.dev@gmail.com

To register for a real world evidence conference, choose a relevant event like the Evidence 360 Summit USA 2026, select your pass type, complete the registration form, and confirm early to secure full access and networking opportunities.

Registering for a real world evidence conference is an important step for professionals in pharma, biotech, and healthcare who want to stay ahead in data-driven decision-making. The right event provides insights into real-world data, pricing strategies, and market access while offering valuable networking opportunities.

If you’re looking for the best real world evidence conference in the USA in 2026, the
2nd Annual EVIDENCE 360: RWE, Pricing and Market Access Summit USA Edition is a leading choice.

Location: Hilton Garden Inn Camden Waterfront, Philadelphia
Date: 08–09 June 2026

Why attend a real world evidence conference in 2026?

A real world evidence conference helps professionals:

  • Understand how real-world data supports regulatory and payer decisions
  • Explore pricing and reimbursement strategies
  • Learn how AI is transforming evidence generation
  • Connect with industry leaders and decision-makers

Events like Evidence 360 bring together pharma, biotech, payers, and solution providers, making them highly valuable for strategic growth.

Step 1: Choose the right real world evidence conference

Before registering, ensure the event matches your goals. A high-quality real world evidence conference should include:

  • Real-world data and HEOR insights
  • Market access and pricing discussions
  • Regulatory and policy perspectives
  • AI and digital health innovations

The Evidence 360 Summit is specifically designed to address these critical areas.

Step 2: Select the right registration pass

Choosing the correct pass ensures you get the most relevant access and networking opportunities.

Pharma & Biotech Pass (Free)

Ideal for pharma and biotech professionals.

Includes:

  • Full conference access (one attendee)
  • Access to networking sessions
  • Lunch and refreshments
  • Event e-brochure
  • E-certificate of attendance

Vendor Delegate Standard Pass – $1,499

Best for individual vendors and solution providers.

Includes:

  • One delegate pass
  • Full conference access
  • Networking sessions
  • Lunch and refreshments
  • Event e-brochure

Vendor Delegate Group Pass – $2,999

Suitable for teams attending together.

Includes:

  • Three delegate passes
  • Full conference access
  • Networking sessions
  • Lunch and refreshments
  • Event e-brochure

Networking Partner – $3,500

Designed for companies focused on partnerships and business development.

Includes:

  • Two delegate passes
  • Full conference access
  • Networking sessions
  • Lunch and refreshments
  • Three one-to-one meetings with selected attendees

Step 3: Complete your registration

To register for a real world evidence conference, follow these steps:

  1. Visit the official registration page
  2. Choose your pass category
  3. Fill in your professional details
  4. Confirm your registration and complete payment (if required)

A smooth and transparent registration process reflects a well-organized conference experience.

Registration at: https://veridonglobal.com/upcoming-conferences/2nd-annual-evidence-360-summit-usa-edition/2nd-annual-evidence-360-usa-registeration/

Step 4: Register early for better opportunities

Early registration helps you:

  • Secure limited free pharma passes
  • Access better networking opportunities
  • Plan meetings and travel in advance

Top conferences like Evidence 360 attract senior-level professionals, so early action is important.

Step 5: Prepare after registration

Once registered, maximize your experience by:

  • Reviewing the agenda in advance
  • Shortlisting key sessions
  • Identifying important speakers
  • Scheduling meetings early

This ensures you gain real insights and meaningful connections.

Why Evidence 360 is a benchmark real world evidence conference

The 2nd Annual EVIDENCE 360: RWE, Pricing and Market Access Summit USA Edition sets a strong benchmark because it offers:

  • A focused agenda on RWE, pricing, and market access
  • Senior-level attendees and industry experts
  • Structured networking opportunities
  • One-to-one business meetings
  • Flexible registration options

This combination makes it one of the top real world evidence conferences in the USA in 2026.

Final thoughts

Registering for a real world evidence conference in 2026 should be a strategic decision. From selecting the right event to choosing the correct pass, each step impacts the value you gain.

The Evidence 360 Summit provides the ideal mix of insights, networking, and practical learning, making it a must-attend event for professionals looking to stay competitive in healthcare and life sciences.

 

2nd Annual HPAPI Summit 2026 – When and Where?

Posted on by veridonglobal.dev@gmail.com

What is the 2nd Annual HPAPI Summit 2026?

The 2nd Annual HPAPI Summit 2026 is a leading European conference focused on the development, manufacturing, safety, and containment of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). Targeted at pharmaceutical professionals, CDMOs, containment engineers, EHS specialists, and quality managers, this summit brings together industry experts to share best practices, regulatory updates, and cutting‑edge technologies for handling potent APIs safely and efficiently.

When and where is the 2nd Annual HPAPI Summit 2026?

The 2nd Annual HPAPI Summit 2026 will take place on:

20–22 May 2026

Venue:

Radisson Blu Hotel Milan

Via Villapizzone 24, Milan, 20156, Italy This centrally located hotel offers modern conference facilities, excellent networking spaces, and easy access to Milan’s international transport links, making it a convenient hub for professionals traveling from across Europe and beyond.

Why attend the 2nd Annual HPAPI Summit 2026?

  • Deep‑dive sessions on HPAPI development, high‑potency formulations, and containment strategies.
  • Regulatory insights into EU and global standards for handling potent compounds safely.
  • Engineering and containment showcases featuring isolators, RABS, cleanrooms, and closed‑system technologies.
  • Networking opportunities with CDMOs, equipment suppliers, regulatory consultants, and pharma leaders.
  • Whether you work in R&D, manufacturing, validation, safety, or quality, the HPAPI Summit 2026 is designed to help you reduce risk, improve efficiency, and stay compliant in a rapidly evolving HPAPI landscape.

How to register for the upcoming HPAPI Conference in Europe?

If you want to attend the 2nd Annual HPAPI Summit 2026 in Milan, you can register through the official event registration portal.

Registration links:

2nd Annual HPAPI Summit 2026 registration:

https://veridonglobal.com/upcoming-conferences/2nd-annual-europotent-360-summit/pharma-cleaning-and-containment-summit-2026-registration/

On the registration page you will typically find:

  • Delegate ticket options (early‑bird, standard, group, and student/academic rates).
  • Agenda and speaker list previews.
  • Networking and sponsorship opportunities for companies and service providers.
  • Hotel and travel information for international attendees.

We recommend registering early to secure your preferred pass type and to benefit from lower‑tier pricing where available.

    Best HPAPI and High Potent Pharmaceutical Conference in Europe

    Posted on by veridonglobal.dev@gmail.com

    Highly Potent Active Pharmaceutical Ingredients (HPAPIs) are critical components used in advanced drug development, especially in oncology and targeted therapies. As the demand for high-potency medicines grows, pharmaceutical professionals are turning to specialized industry events such as the EuroPotent 360 Summit to explore innovations in containment technologies, safety practices, and regulatory compliance.

    The pharmaceutical industry is rapidly advancing with the increasing use of Highly Potent Active Pharmaceutical Ingredients (HPAPIs) in modern drug development. These compounds are widely used in the treatment of complex diseases such as cancer, autoimmune disorders, and other targeted therapies. Because HPAPIs are extremely powerful even in very small doses, they require specialized manufacturing environments, strict safety measures, and advanced containment technologies.

    As global pharmaceutical companies expand their pipelines of potent drugs, the need for collaboration, innovation, and regulatory knowledge has become more important than ever. Industry conferences dedicated to HPAPI manufacturing and containment systems provide valuable opportunities for professionals to learn about emerging technologies, safety strategies, and regulatory requirements.

    One of the most anticipated industry events addressing these topics is the EuroPotent 360 Summit organized by Veridon Global, widely recognized as the best HPAPI conference in Europe 2026 for professionals working in high-potency pharmaceutical manufacturing and containment solutions.

    Understanding the Importance of HPAPIs in Modern Medicine

    Highly Potent Active Pharmaceutical Ingredients are compounds that produce strong pharmacological effects at very low concentrations. These ingredients are commonly used in specialized therapeutic areas where high potency and targeted drug delivery are essential.

    In recent years, HPAPIs have become increasingly important in pharmaceutical research and production due to several key factors:

    • Growth of oncology drugs and targeted cancer therapies
    • Increasing demand for antibody-drug conjugates (ADCs)
    • Development of highly specialized biologics and small-molecule drugs
    • Expansion of personalized medicine approaches

    However, the manufacturing and handling of HPAPIs present unique challenges. Even minimal exposure can pose health risks to workers if appropriate containment systems are not implemented. As a result, pharmaceutical companies must invest in advanced facilities, safety protocols, and regulatory compliance strategies.

    Industry conferences focusing on HPAPI technologies help professionals stay informed about these evolving challenges and solutions.

    EuroPotent 360 Summit by Veridon Global

    The EuroPotent 360 Summit is a specialized pharmaceutical conference that focuses on the entire lifecycle of highly potent compounds, including development, containment, manufacturing, and regulatory compliance.

    The event is organized by Veridon Global, a global conference organizer known for hosting industry-focused events that bring together pharmaceutical leaders, technology providers, and regulatory experts.

    Event Details

    • Conference: EuroPotent 360 Summit
    • Dates: 20–22 May 2026
    • Location: Milan, Italy
    • Venue: Radisson Blu Hotel Milan

    The conference provides a platform for global experts to discuss practical strategies for managing high-potency pharmaceutical ingredients safely and efficiently.

    Participants will gain insights into the latest developments in containment engineering, occupational safety, regulatory compliance, and pharmaceutical manufacturing technologies.

    Key Topics Covered at the EuroPotent 360 Summit

    The EuroPotent 360 Summit focuses on several important areas related to HPAPI production and management. The agenda is designed to provide practical solutions and industry insights for pharmaceutical professionals.

    1. HPAPI Containment Technologies

    Containment systems play a critical role in preventing exposure to highly potent compounds. Experts at the summit will present new technologies such as:

    • Advanced isolator systems
    • Barrier containment technologies
    • Closed transfer systems
    • High-performance filtration solutions

    These innovations help pharmaceutical companies maintain safe working environments while ensuring product integrity.

    2. Facility Design for High-Potency Manufacturing

    Designing facilities that handle HPAPIs requires careful planning and specialized engineering. The conference will explore best practices in facility design, including:

    • Segregated manufacturing areas
    • Controlled airflow systems
    • Containment laboratories
    • Integrated monitoring technologies

    These design strategies are essential for preventing cross-contamination and maintaining compliance with international regulations.

    3. Cross-Contamination Prevention

    Cross-contamination is one of the most critical challenges in multiproduct pharmaceutical facilities. The EuroPotent 360 Summit will provide insights into:

    • Cleaning validation strategies
    • Risk-based contamination control approaches
    • Advanced monitoring and testing techniques

    Industry experts will also share case studies demonstrating how pharmaceutical companies successfully manage contamination risks in complex manufacturing environments.

    4. Regulatory Compliance and Industry Guidelines

    Regulatory authorities across the world continue to strengthen safety requirements for handling highly potent compounds. The summit will address regulatory expectations and compliance strategies for pharmaceutical organizations operating in global markets.

    Topics include:

    • Good Manufacturing Practice (GMP) compliance
    • Regulatory inspection readiness
    • Risk-based containment frameworks
    • Occupational exposure limits (OELs)

    These sessions help organizations stay aligned with international regulatory standards.

    5. Occupational Safety and Exposure Monitoring

    Worker safety is a critical priority in facilities that handle potent pharmaceutical compounds. The conference will highlight modern exposure monitoring systems and protective technologies designed to protect employees.

    Sessions will discuss:

    • Environmental monitoring systems
    • Worker exposure assessment
    • Personal protective equipment strategies
    • Engineering controls for HPAPI containment

    These approaches help ensure safe operations across pharmaceutical manufacturing environments.

    Networking and Industry Collaboration

    In addition to technical presentations, the EuroPotent 360 Summit offers valuable networking opportunities for professionals across the pharmaceutical ecosystem.

    Participants can connect with:

    • Pharmaceutical manufacturers
    • Biotechnology companies
    • Contract development and manufacturing organizations (CDMOs)
    • Engineering and containment technology providers
    • Regulatory and compliance specialists

    These interactions create opportunities for collaboration, partnerships, and knowledge exchange that can drive innovation in the pharmaceutical sector.

    Why Milan Is a Key Destination for Pharmaceutical Conference

    Milan has become an important hub for international pharmaceutical events due to its strong biotechnology ecosystem and strategic location in Europe. The city hosts numerous scientific conferences and industry gatherings that attract professionals from around the world.

    Milan offers:

    • Excellent international connectivity
    • Advanced conference infrastructure
    • A thriving pharmaceutical and biotechnology industry
    • Access to leading research institutions and universities

    These advantages make Milan an ideal location for global industry events such as the EuroPotent 360 Summit.

    Who Should Attend the EuroPotent 360 Summit?

    The conference is designed for professionals involved in the research, development, and manufacturing of highly potent pharmaceutical compounds.

    Key attendees include:

    • Pharmaceutical manufacturing executives
    • Process engineers and facility designers
    • Environmental health and safety (EHS) specialists
    • Quality assurance and quality control professionals
    • Regulatory affairs experts
    • Biotechnology researchers
    • Containment technology providers

    For these professionals, the summit provides valuable insights into emerging technologies and industry best practices.

    Conclusion

    The growing demand for high-potency medicines has transformed the pharmaceutical manufacturing landscape. As companies continue to develop targeted therapies and complex drugs, the need for advanced containment strategies, regulatory compliance, and innovative technologies will only increase.

    Industry events like the EuroPotent 360 Summit play a crucial role in helping professionals stay informed and connected. By bringing together experts from across the pharmaceutical value chain, the conference encourages collaboration and knowledge sharing that drives progress in HPAPI manufacturing. For professionals looking to stay ahead in this rapidly evolving field, the EuroPotent 360 Summit stands out as the best HPAPI conference in Europe 2026, offering valuable insights, networking opportunities, and practical solutions for the future of high-potency pharmaceutical production.

    FAQ Section:

    1. What is an HPAPI conference?
    An HPAPI conference is an industry event focused on highly potent active pharmaceutical ingredients, covering topics such as containment technologies, regulatory compliance, occupational safety, and high-potency drug manufacturing.

    2. Why are HPAPI conference important for the pharmaceutical industry?
    HPAPI conferences help professionals stay updated on the latest developments in containment systems, manufacturing technologies, safety protocols, and global regulatory requirements for handling highly potent pharmaceutical compounds.

    3. Where is the EuroPotent 360 Summit held?
    The EuroPotent 360 Summit is held in Milan, Italy, bringing together pharmaceutical professionals and industry experts from across Europe and other regions.

    4. Who should attend an HPAPI conference?
    HPAPI conferences are ideal for pharmaceutical manufacturers, containment engineers, regulatory affairs specialists, EHS professionals, quality assurance experts, and biotechnology researchers working with potent compounds.5. What topics are covered at the EuroPotent 360 Summit?
    The summit covers topics such as HPAPI containment technologies, facility design, cross-contamination control, occupational safety, and regulatory compliance for highly potent pharmaceutical manufacturing.